Table of Contents
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered for the Study
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
5.2 Market Dynamics
6 Mouth Ulcers Treatment Market, By Drug Type
6.5 Others (If Any)
7 Mouth Ulcers Treatment Market, By Formulation
7.5 Others (If Any)
8 Mouth Ulcers Treatment Market, By Indication
8.1 Aphthous Stomatitis
8.2 Oral Lichen Planus
8.3 Others (If Any)
9 Mouth Ulcers Treatment Market, By Region
9.2 North America
9.4 Asia Pacific
10 Competitive Landscape
10.1 Market Overview
10.2 Market Ranking Analysis, 2018
10.3 Competitive Situation and Trends
10.3.1 Product Launches & Approval
10.3.4 Other Developments
11 Company Profiles
(Business Overview, Products Offered, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments.)*
11.1 Blistex, Inc.
11.2 Glaxosmithkline PLC.
11.3 Pfizer Inc
11.4 Bristol Myers Squibb
11.5 Colgate- Palmolive Company
11.6 Church & Dwight Co., Inc.
*Details on Business Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Key Relationships Might Not Be Captured in Case of Unlisted Companies.
Mouth ulcers, also called as canker sores, are painful sores that are formed on the soft tissue in the mouth including lips, cheek, tongue, floor and roof of the mouth, and gums. Mouth ulcers can make it difficult for some patients to eat, drink, and brush teeth. Most mouth ulcers are benign and recurring and get cleared up within 1-2 weeks on their own. Some common causes of mouth ulcer are acidic foods, biting the tongue or inside of the cheek, braces, poor-fitting dentures, and other apparatus that may rub against the mouth and gums, deficiency of vitamins, stress, anxiety, infections, and may be a sign of other diseases such as Crohn's disease, celiac disease, or HIV.
The report provides an overall understanding of the global mouth ulcer treatment market. This report segments the market on the basis of drug type, formulation, indications, and region.
On the basis of drug type, the market is segmented antimicrobial, antihistamine, analgesic, corticosteroids, and anesthetics. On the basis of formulations the market is divided into mouthwash, sprays, gels, lozenges, and ointments. On the basis of indications, the market is segmented into aphthous stomatitis, oral lichen planus, and other diseases. On the basis of region, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is further divided into US and Canada.
A combination of bottom-up and top-down approaches will be used to calculate the market sizes and growth rates of the global mouth ulcer treatment market and its sub segments. All percentage shares, splits, and breakdowns are determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study will be taken into account, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders will also be used to determine the percentage shares of each sub segment and the relative differences in growth rates.
This research report categorizes the global mouth ulcer treatment market into the following segments and sub segments:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
The mouth ulcer treatment market is segmented based on drug type, formulations, indications, and region. North America is expected to dominate the market in 2018, with the US accounting for a major share. However, Asia Pacific is expected to grow at the highest CAGR during the forecast period.
Benchmarking the rapid strategy shifts of the Top 100 companies in the Mouth Ulcer Treatment MarketRequest For Special Pricing